Skip to content
Government Federal, Medical Health Aged Care

PHAA thanks Professor Paul Kelly, outgoing Chief Medical Officer, for his commitment to public health

Public Health Association of Australia < 1 mins read

8 October 2024

The Public Health Association of Australia (PHAA) acknowledges the contribution of Professor Paul Kelly as he announces his departure from the role of Chief Medical Officer of Australia (CMO) and Director of the Interim Centre for Disease Control.

Professor Kelly commenced as Deputy CMO in January 2020 as COVID-19 was emerging. He became acting CMO in July 2020 and was appointed CMO in January 2021.

“A public health physician and infectious disease epidemiologist, Professor Kelly was the right man to offer leadership to Australia during the COVID-19 pandemic,” said PHAA CEO, Adjunct Professor Terry Slevin.

“Few people will appreciate the extraordinary pressures and challenges of being the Chief Medical Officer during a global health emergency. Professor Kelly played a vital role in helping Australia navigate through that crisis.

“All people in Australia owe Professor Kelly a debt of gratitude for his dedication and leadership during a perilous time in history.

“We also thank Professor Kelly for his commitment to the development of the Australian Centre for Disease Control.

“We wish Professor Kelly all the best in his future endeavours.”


About us:

About the Public Health Association of Australia

We’re Australia's peak body for public health and advocate for the health and wellbeing of everyone. We strive to help prevent, rather than cure, illness and disease.

Our campaigns and activities span numerous public health issues from environmental health, immunisation and pandemic control, through to tobacco, gambling, physical activity, junk food marketing, preventive mental health, health education and Aboriginal and Torres Strait Islander health.

Our 2,000+ individual members represent over 40 professional groups interested in the promotion of public health. We also have branches in every State and Territory. Learn more at phaa.net.au


Contact details:

Jasmine Lykissas, PHAA Communications Officer, 0481159618, [email protected]  

Media

More from this category

  • Medical Health Aged Care
  • 18/12/2025
  • 22:11
BeOne Medicines Ltd.

BeOne Medicines Granted U.S. FDA Fast Track Designation for BGB-B2033 as Treatment for Hepatocellular Carcinoma

BGB-B2033 is a bispecific antibody directed at GPC3 and 4-1BB; key targets in the most common liver cancer FDA Fast Track Designation reflects the…

  • Contains:
  • Medical Health Aged Care
  • 18/12/2025
  • 19:11
Takeda Pharmaceutical Company Limited

Takeda’s Zasocitinib Landmark Phase 3 Plaque Psoriasis Data Show Promise to Deliver Clear Skin in a Once-Daily Pill, Catalyzing a New Era of Treatment

Pivotal Phase 3 studies of once-daily oral zasocitinib met all primary and ranked secondary endpoints in patients with moderate-to-severe plaque psoriasis More than half…

  • Contains:
  • Medical Health Aged Care
  • 18/12/2025
  • 12:24
La Trobe University

Cell death discovery could aid cancer treatments

LaTrobe researchers have made a groundbreaking discovery about the way dying cells are cleared from our bodies, which could have important impacts on recovery from diseases including cancer infection and inflammatory diseases. Traditionally, it was believed dying cells were broken into smaller pieces by the cell’s own internal machinery, enabling the pieces to be more easily removed from the body. However the study, led by scientists at the La Trobe Institute for Molecular Science and Research Centre for Extracellular Vesicles found that the process of dying cell fragmentation is actually assisted by neighbouring cells. Published in Science Advances, the study…

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.